ArticleThe Analyst2026
Advanced multimodal imaging: FLIM, PLIM, and FluoRaman enabled by novel diarylacetylene probes.
Article in The Analyst, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In drug design, understanding the subcellular localisation and physicochemical behaviour of candidate molecules is essential for optimising their efficacy and elucidating their mechanisms of action. Imaging probes are routinely employed for this purpose, though most studies rely on a single imaging modality. By integrating multiple imaging techniques into a multimodal system, a more comprehensive understanding of localisation, microenvironment, and physicochemical interactions can be achieved. Yet, there remains a scarcity of specialised imaging probes with well-defined photophysical profiles, especially those that combine luminescence with a Raman-active tag in the cell-silent region, where signal clarity is maximised. Such probes could function independently or be conjugated to drugs or targeting moieties as dual-mode imaging tags. In this study, we showcase the application of a suite of advanced imaging modalities: fluorescence microscopy (CLSM); Fluorescence Lifetime Imaging Microscopy (FLIM); Phosphorescence Lifetime Imaging Microscopy (PLIM); and simultaneous fluorescence and Raman spectroscopy (FluoRaman). The modalities were exemplified by a series of novel, highly solvatochromic diarylacetylene-based photosensitisers that feature alkyne Raman tags and exhibit diverse subcellular localisation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.